Image-Based High-Content Analysis, Stem Cells and Nanomedicines: A Novel Strategy for Drug Discovery - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 280

72. Juliano R, McCullough H. Controlled delivery of an antitumor drug:
localized action of liposome encapsulated cytosine arabinoside
administered via the respiratory system. J Pharmacol Exp Ther . 1980
Aug; 214(2):381-387.
73. Takada K, Yoshimura H, Shibata N, Masuda Y, Yoshikawa H, Muranishi S,
et al. Eff ect of administration route on the selective lymphatic delivery
of cyclosporin A by lipid-surfactant mixed micelles. J Pharmacobiodyn .
1986 Feb; 9(2):156-160.
74. Widder K, Senyel A, Scarpelli G. Magnetic microspheres: a model
system of site specific drug delivery in vivo . Proc Soc Exp Biol Med .
1978 Jun; 158(2):141-146.
75. Vinogradov S, Bronich T, Kabanov A. Nanosized cationic hydrogels for
drug delivery: preparation, properties and interactions with cells. Adv
Drug Deliv Rev. 2002 Jan; 54(1):135-147.
76. Burger K, Staffhorst R, de Vijlder H, Velinova M, Bomans P, Frederik
P, et al. Nanocapsules: lipid-coated aggregates of cisplatin with high
cytotoxicity. Nat Med . 2002 Jan; 8(1):81-84.
77. Weckenmann H, Matzku S, Stricker H. Optimisation of the covalent
binding of monoclonal antibodies to liposomes. Arzneimittelforschung .
1988 Nov; 38(11):1556-1563.
78. Hagiwara A, Takahashi T. A new drug-delivery-system of anticancer
agents: activated carbon particles adsorbing anticancer agents. In
Vivo . 1987 1987 Jul-Aug; 1(4):241-252.
79. Begley D. Delivery of therapeutic agents to the central nervous
system: the problems and the possibilities. Pharmacol Ther . 2004 Oct;
104(1):29-45.
80. Pignatello R, Pantò V, Salmaso S, Bersani S, Pistarà V, Kepe V, et
al. Flurbiprofen derivatives in Alzheimer's disease: synthesis,
pharmacokinetic and biological assessment of lipoamino acid
prodrugs. Bioconjug Chem . 2008 Jan; 19(1):349-357.
81. Deguchi Y, Hayashi H, Fujii S, Naito T, Yokoyama Y, Yamada S, et al.
Improved brain delivery of a nonsteroidal anti-inflammatory drug
with a synthetic glyceride ester: a preliminary attempt at a CNS drug
delivery system for the therapy of Alzheimer's disease. J Drug Target .
2000; 8(6):371-381.
82. Reese T, Karnovsky M. Fine structural localization of a blood-brain
barrier to exogenous peroxidase. J Cell Biol . 1967 Jul; 34(1):207-217.
83. Ermisch A. Peptide receptors of the blood-brain barrier and substrate
transport into the brain. Prog Brain Res . 1992; 91:155-161.